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In the brain, REST (Repressor Element-1 Silencing Transcription factor) is
a key regulator of neuron cell-specific gene expression. Nuclear translocation
of neuronal REST has been shown to be neuroprotective in a healthy ageing
context. In contrast, inability to upregulate nuclear REST is thought to leave
ageing neurons vulnerable to neurodegenerative stimuli, such as Alzheimer’s
disease (AD) pathology. Hippocampal and cortical neurons are known to be
particularly susceptible to AD-associated neurodegeneration. However,
REST expression has not been extensively characterised in the healthy age-
ing brain. Here, we examined the spatiotemporal immunolocalisation of
REST in the brains of healthy ageing wild-type Fischer-344 and transgenic
Alzheimer’s disease rats (TgF344-AD). Nuclear expression of REST
increased from 6 months to 18 months of age in the hippocampus, frontal
cortex and subiculum of wild-type rats, but not in TgF344-AD rats. No
changes in REST were measured in more posterior cortical regions or in the
thalamus. Interestingly, levels of the presynaptic marker synaptophysin, a
known gene target of REST, were lower in CA1 hippocampal neurons of
18-month TgF344-AD rats compared to 18-month wild-types, suggesting
that elevated nuclear REST may protect against synapse loss in the CA1 of
18-month wild-type rats. High REST expression in ageing wild-type rats did
not, however, protect against axonal loss nor against astroglial reactivity in
the hippocampus. Taken together, our data confirm that changes in nuclear
REST expression are context-, age- and brain region-specific. Moreover, key
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brain structures involved in learning and memory display elevated REST
expression in healthy ageing wild-type rats but not TgF344-AD rats.
Alzheimer’s disease (AD) is a progressive neurodegen-
erative disorder characterised by profound memory
loss, personality changes, apathy and language impair-
ments [1]. Many genetic risk factors for AD, including
the e4 isoform of apolipoprotein E (ApoE4), have
been identified [2]. However, the most profound non-
genetic risk factor for AD is ageing and the deteriora-
tion of homeostatic physiological systems [3]. In
approximately 90% of AD cases, patients are older
than 65 years and the incidence of AD doubles with
every 5 years over the age of 65 [4]. At the cellular
level, classic hallmarks of AD include extracellular
amyloid-b1–42 (Ab1–42) plaques, intracellular neurofib-
rillary tangles of hyperphosphorylated tau, neurode-
generation, loss of synapses and extensive
neuroinflammation [4–6].
The cognitive decline observed in AD patients corre-
lates closely with synaptic dysfunction [7]. Disruption
of synaptic plasticity, ultimately resulting in the loss of
synapses and neurodegeneration, is regarded as a com-
mon pathological event in AD [8–10], whereas neu-
ronal plasticity is largely preserved in the hippocampal
and cortical regions of the healthy ageing brain [10].
As well as synaptic dysfunction, AD is associated with
high levels of chronic neuroinflammation [4]. Glial
cells can sense and respond to Ab1–42 deposition in
hippocampal and cortical brain regions in an attempt
to engulf and degrade the toxic peptide aggregates.
However, activated glial cells release a cascade of pro-
inflammatory cytokines and chemokines, which exacer-
bate the pathogenic process [11]. Moreover, it has been
suggested that AD-associated neuroinflammation may
contribute more to the pathogenesis of the disease,
compared to the impact of amyloid-b plaques and tau
tangles themselves [12].
Recently, the transcriptional repressor REST
(RE1-silencing transcription factor), also known as
NRSF (Neuron-Restrictive Silencer Factor), was shown
to play a crucial role in neuroprotection in the ageing
brain [13]. REST is a known transcriptional regulator
of more than 2000 neuron-specific target genes that
encode for a plethora of proteins involved in synaptic
plasticity (e.g., Syp), neurotransmitter receptors (e.g.,
Grin2A), ion channel formation (e.g., HCN1) and axo-
nal guidance (e.g., L1CAM) [14]. Whilst neuronal
REST normally resides inactive in the cytoplasm of
differentiated neurons, ‘healthy ageing’ is associated
with a significant induction of REST in neuronal nuclei
in the prefrontal cortex. In contrast, this age-related
induction of nuclear REST was less apparent in
patients with mild cognitive impairment (MCI) and
almost completely absent in AD patients [13]. Upregu-
lation of active REST was observed in the nucleus of
human prefrontal cortical neurons during healthy age-
ing and was found to transcriptionally repress genes
involved in neuronal cell death (e.g., MAPKII, FADD,
PUMA) and AD-related genes (e.g., presenilin 2, c-sec-
retase and CDK5R1), thereby providing age-related
neuroprotection [13]. Furthermore, the ageing-induced
increase in nuclear REST was shown to protect neurons
from Ab1–42 pathology and oxidative stress [13,15,16].
In contrast, in human neuropathological diseases,
including AD and Parkinson’s disease which are both
hallmarked by protein misfolding and aggregation,
REST does not translocate to neuronal nuclei to exert
its protective functions [13,16].
These findings suggest that nuclear REST expression
confers neuroprotection in the ageing brain. However,
REST-dependent gene regulation is highly cell-type
specific, as well as brain region and context-dependent
[17]. On one hand, nuclear translocation of REST in
the hippocampus of healthy ageing humans was shown
to be neuroprotective [13]. On the other hand, REST
nuclear translocation in response to ischaemia and sei-
zures has been linked to the death of hippocampal
neurons [14]. In Huntington’s disease, aberrant accu-
mulation of REST occurs in the nuclei of vulnerable
striatal neurons [18]. Whilst in Parkinson’s disease,
nuclear translocation of REST does not occur in
dopaminergic neurons of the substantia nigra (SN) or
neocortex [16]. These apparently opposing actions of
REST are analogous to the complex role of various
cytokines in the brain. For example, relatively high
concentrations of cytokines released for chronic time-
periods can be detrimental, but lower concentrations
present for acute periods can potentiate neuronal func-
tion [19]. Overall, the transcription factor REST is a
promising therapeutic target in AD and other neurode-
generative diseases. However, very little is known
about ageing-associated changes in REST expression
and distribution patterns throughout the healthy age-
ing brain and the Alzheimer’s diseased brain.
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Therefore, we investigated the spatiotemporal
localisation of REST in healthy ageing and Alzhei-
mer’s disease rat brains. The aim was to visualise
changes in nuclear REST expression throughout the
brain of healthy ageing rats and to contrast this with a
transgenic model of AD. The TgF344-AD rat model
[20] overexpresses human amyloid precursor protein
(APP) with the Swedish mutation (APPSWE) and
mutated human presenilin-1 (PSEN1DE9). REST
expression was quantified by immunofluorescence in
brain sections from wild-type (WT) Fischer-344 and
transgenic (TG) rats. We focused on brain regions
involved in learning and memory which are affected
by AD pathology, including the hippocampus and cor-
tical regions. To investigate the potential relationship
between REST levels and pathological hallmarks of
AD, we also quantified changes in the abundance of
protein and peptide markers associated with amyloid
plaques (Ab1–42), synaptic dysfunction (synapto-
physin), age-related neuronal atrophy (neurofilament-
H) and neuroinflammation-induced astrogliosis, that
is, glial fibrillary acidic protein (GFAP).
Materials and methods
Ethics statement
All experiments involving animals and Schedule 1 protocols
used to obtain brain tissue were approved by the Animal
Welfare and Ethical Review Body (AWERB committee) of
the University of Manchester. This study was conducted in
accordance with the principles of the Basel Declaration and
adhered to the legislation detailed in the UK Animals (Sci-
entific Procedures) Act 1986 Amendment Regulations (SI
2012/3039). All efforts were taken to maximise animal wel-
fare conditions and to reduce the number of animals used
in accordance with the European Communities Council
Directive of 20 September 2010 (2010/63/EU).
Fischer-344 and TgF344-AD rats
Two male and two female wild-type (WT) Fischer-344 and
TgF344-AD (TG) rats with the APPSWE and PSEN1DE9
mutations were purchased from Prof T. Town laboratory
(University of Southern California, USA) and were set up
as breeding pairs in-house at the Biological Services Unit
(BSU) in the University of Manchester, UK. TG rats and
WT littermates were separated into different cages for the
ageing studies. For immunohistological assessment, the
number (n) of rats per group is detailed in the correspond-
ing figure legend. All animals used were male and were
housed in groups of two to four per cage with individual
ventilation, environmental enrichment and access to food
and water ad libitum. A 12-h light/dark cycle was used,
with light from 7 am until 7 pm, in a holding room
maintained at 21  1 °C and ~ 55% relative humidity.
Tissue sectioning
TgF344-AD and WT rats were euthanised using an isoflu-
rane overdose, confirmed by cervical dislocation. The
brains were collected, snap-frozen using isopentane on dry
ice and stored at 80 °C. Sagittal brain sections (20 µm
thick) between 1 mm and 3.36 mm lateral to Bregma were
cut using a cryostat (Leica CM3050s, Leica Biosystems,
Germany) and stored at 80 °C. Prior to immunofluores-
cence, frozen sections were removed from the 80 °C free-
zer and allowed to air dry at 22 °C for 20 min before
fixation in 70% ethanol for 30 min. They were then perme-
abilised in 0.2% Triton-X/PBS for 30 min, followed by sev-
eral PBS washes, and then blocked with 5% BSA in PBS
for 1.5 h at 22 °C.
Immunohistochemistry
Sections from WT Fischer-344 and TgF344-AD rats were
incubated overnight at 22  2 °C with the following pri-
mary antibodies, (1) 1 : 1000 dilution of rabbit anti-amy-
loid b1–42 (mOC98) (ab201061, RRID: AB_2722492,
Abcam, Cambridge, UK), a conformation-specific antibody
that recognises a discontinuous epitope of Ab that maps to
segments AEFRHD and EDVGSNK; (2) 1 : 1000 dilution
of chicken antiglial fibrillary acidic protein (GFAP)
(ab4674, RRID: AB_304558, Abcam); (3) 1 : 500 dilution
of rabbit anti-REST (ab202962, Abcam); (4) 1 : 5000 dilu-
tion of chicken antineurofilament heavy chain (NFH)
(ab5539, RRID: AB_11212161, Merck Millipore, Watford,
UK); (5) 1 : 2000 dilution of mouse anti-synaptophysin
(7H12) (9020S, RRID: AB_2631095, Cell Signalling, Lei-
den, The Netherlands). Slides were then washed in PBS
and incubated for 4 h at 22 °C with the following sec-
ondary antibodies, (1) donkey anti-rabbit 555
(SAB4600061, Merck, Darmstadt, Germany), (2) donkey
anti-chicken IgY (H + L) CFTM 633 (SAB4600127, Merck)
and (3) donkey anti-mouse Alexa 555 (ab150110, Abcam).
Finally, slides were washed, and cover slipped using Pro-
Long Gold antifade mounting medium with DAPI
(P36935, Thermofisher Scientific, Cambridge, UK).
Microscopy
All images of REST, Ab1–42 peptide, GFAP, NFH and
synaptophysin (Syp) expression in sagittal cryosections were
captured using an Axio Scan.Z1 slide scanner (Zeiss,
Munich, Germany) with a 209 magnification objective
(Plan-Apochromat). Individual images were montaged
together automatically in ZEN software (Zeiss) to recon-
struct a single image of the whole brain section. For
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quantitative fluorescence intensity analysis, all images were
captured in a single uninterrupted run (~50 h imaging time)
and uniform microscope settings were maintained through-
out the session. The images were exported as 8-bit.tif files
for fluorescence intensity quantification.
Image analysis of amyloid plaque expression
Image analysis for Ab1–42 was conducted using the software
package ImageJ [21]. Briefly, Ab1–42 fluorescence intensity
was quantified by manually selecting 10 regions of interest
(ROI) for each brain structure and calculating the average
fluorescence intensity within each ROI. Ab1–42 morphologi-
cal analysis was performed using the particle analyser com-
mand in ImageJ software [22]. Images were thresholded
and made binary, holes were filled, and particles were anal-
ysed showing the number of particles per area and the
perimeter. The following sequence of commands was used:
Open image > Threshold > Make binary > Fill holes > Out-
line > Analyse particles. Data are presented as the average
number of plaques per mm2, the average perimeter of each
plaque (µm) and the mean Ab1–42 fluorescence intensity.
Image analysis of REST expression
Analysis of REST expression was conducted using images
captured from two distinct immunolabelled brain sections,
with 4–8 animals per age-group and genotype, as described
in the figure legends. The occipital, parietal, cingulate and
frontal cortices as well as the thalamus, subiculum and hip-
pocampal CA and dentate gyrus regions were chosen for
analysis due to previous reports of significant AD-like
pathology in these brain areas of the TgF344-AD rat
model [20,23]. The aim was thus to measure changes in
nuclear REST expression with age and AD pathogenesis in
these regions. In the hippocampus, only regions containing
principal neuronal cell bodies (i.e., stratum pyramidale of
the CA1 and CA3, and stratum granulosum of the DG)
were analysed. Fluorescence channels were split and con-
verted to greyscale. Changes in nuclear REST expression
were measured using the open-source image analysis soft-
ware, CellProfiler [24]. Briefly, nuclei were automatically
detected using DAPI staining as a nuclear marker and the
co-localised intensity of REST fluorescence was measured.
Specifically, the following sequence of commands was used:
Import images > Convert Color to Gray > Identify Primary
Objects > Identify Secondary Objects > Measure Object
Intensity. Data are presented as mean nuclear REST fluo-
rescence intensity (see Fig. S1 for further details).
Image analysis of Synaptophysin expression
Analysis of synaptophysin expression in the hippocampus
was also performed using two immunolabelled brain
sections from 4–8 animals per age-group and genotype.
Mean fluorescence intensities in the CA1, CA3 and dentate
gyrus regions were measured using ImageJ software [21,25].
Briefly, five same-sized ROIs were drawn within each hip-
pocampal region and the mean fluorescence intensity within
each ROI was measured. Data are presented as the average
synaptophysin fluorescence intensity per animal for each
hippocampal region analysed.
Image analysis of axonal density and diameter
Quantification of axonal density and diameter was per-
formed using a Hessian-based feature in ImageJ. NFH-la-
belled images from two different brain sections from 4–8
animals per age-group and genotype were used. Only neu-
rons within the CA1, CA3 and DG regions of the hip-
pocampus were measured for this analysis. Here, the
ImageJ software plug-in, FeatureJ, was used to extract line-
like information through a Hessian-based filter [26,27]. The
following parameters in the plug-in for Hessian analysis
were selected: (1) Largest eigenvalue of Hessian tensor; (2)
Absolute eigenvalue comparison; (3) Smoothing scale fac-
tor = 0.5. These settings create an image of the largest
eigenvalues after absolute values of Hessian matrices com-
parison. Next, a line scan profile analysis was performed
using the ImageJ ‘Line’ tool by drawing a straight line
through each region of interest. Pixel intensity across this
line was plotted using the ‘Plot Profile’ tool in ImageJ. All
the line scan data were imported to R for further analysis.
Here, the mean number of peaks per unit area (mm) was
calculated to measure axonal density. To measure changes
in axonal diameter, the width of each peak at half-height
were calculated.
Image analysis of hippocampal astrogliosis
GFAP-labelled images from two distinct brain sections
from 4–9 animals per age-group and genotype were used.
Astrocytic morphology was analysed using the IMAGEJ soft-
ware plug-in, BONEJ [28]. Briefly, after thresholding and
selecting the hippocampal region of interest (CA1, CA3 or
DG), the image was made binary and skeletonised. Data
are presented as the number of GFAP-positive astrocyte
branches per area (mm2) and the average branch length
(µm).
Statistical analysis
All statistical analysis was performed using GRAPHPAD
PRISM 7 (RRID: SCR_015807). Assessment of normality
was carried out using D’Agostino analysis. To analyse
changes in fluorescence intensities, one-way or two-way
ANOVAs were performed, as appropriate, on the raw fluo-
rescence values, followed by Holm-Sidak multiple
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comparisons post hoc tests. Changes in expression were
considered significant when the P value < 0.05.
Results
Amyloid plaque pathology increases with age in
the hippocampus of TgF344-AD rats
We first investigated the gradual increase in amyloid
plaque burden in the hippocampus of adult transgenic
rats. Sagittal sections of the TgF344-AD rat brain
were cryosectioned and immunolabelled for Ab1–42
(amyloid plaques), as well as GFAP (astrocytes) and
the cell nucleus counterstain DAPI (Fig. 1A–D).
Extensive plaque pathology was apparent in the hip-
pocampus and neocortex of 18-month (18m) TgF344-
AD rat brains (Fig. 1C) and to a lesser extent in the
thalamus, cerebellum, and striatum. In comparison,
very few amyloid plaques were visualised in the
medulla, pons or ventral midbrain structures, although
the inferior colliculus (auditory integration centre) in
the dorsal midbrain did show signs of amyloid plaque
pathology. An increase in astrocyte reactivity/hyper-
trophy was evident from 6 to 18 months of age
(Fig. 1E–G), particularly in the hilus region of the
dentate gyrus and around amyloid plaques, as
described previously by others [29–31]. Coinciding with
this increase in astrocyte reactivity was an enhanced
deposition of Ab1–42 and accumulation of amyloid
plaques in all areas of the hippocampus from 6 to
18 months of age. (Fig. 1H–J). Hippocampal amyloid
plaque characteristics were quantified using IMAGEJ
software (Fig. 1K, L). The density (number of plaques
per mm2), size (average perimeter) and fluorescence
intensity of amyloid plaques increased in TgF344-AD
rats from 6 to 18 months of age (Fig. 1M–O).
REST expression increases with age in the
subiculum and frontal cortical regions of wild-
type rats
Our next aim was to assess the relative expression of
REST throughout different regions of the adult rat
brain. Wild-type and TgF344-AD rat brains (6, 12 and
18 months) were sectioned and immunolabelled for
REST (Fig. 2A–G). A representative image from a 12-
month wild-type rat is shown in Fig. 2A. REST
expression was notably higher in grey matter versus
white matter regions of the brain. The corpus callo-
sum, for example, displayed low levels of REST
expression. Areas of the brain that contained higher
levels included the anterior olfactory nucleus (Fig. 2B),
striatum (Fig. 2C), neocortex (Fig. 2D), thalamus
(Fig. 2E), subiculum (Fig. 2F), Purkinje cells of the
cerebellum (Fig. 2G) and principal neurons of the hip-
pocampal cell layers. The pons, medulla and midbrain
structures also contained relatively high nuclear REST
expression. We first quantified REST fluorescence
intensity in DAPI-labelled nuclei of the neocortex,
subiculum and thalamus, areas that showed relatively
high expression of amyloid plaque pathology in
TgF344-AD rats. The neocortex was divided into four
distinct subregions, that is, the occipital, parietal, cin-
gulate and frontal cortices (Fig. 3A). There were no
differences in mean nuclear REST intensities between
wild-type and TgF344-AD rats. Moreover, there were
no changes in REST expression in the thalamus, nor
in the occipital, parietal and cingulate cortices with
advancing age (Fig. 3B–E). However, REST expres-
sion increased from 6 to 18 months in the subiculum
(mean = 0.14, 95% CI = [0.09, 0.19] vs 0.21, 95%
CI = [0.19, 0.23] arbitrary fluorescence units (a.f.u.),
P < 0.05) and frontal cortex (mean = 0.14, 95%
CI = [0.09, 0.18] vs 0.25, 95% CI = [0.19, 0.31] a.f.u.,
P < 0.05) of wild-type rats (Fig. 3F, G), but this effect
was not observed in TgF344-AD rats.
Ageing increases REST expression in the
hippocampus of wild-type rats
Nuclear REST expression was also measured in the
hippocampal CA1, CA3 and dentate gyrus of wild-
type and TgF344-AD rats (Fig. 4A, B). Mean REST
intensity increased in the CA1 region of wild-type rats
from 6 to 12 months of age (mean = 0.16, 95%
CI = [0.13, 0.18] vs 0.22, 95% CI = [0.18, 0.25] a.f.u.,
P < 0.05). The levels of REST remained elevated in
18-month-old WT rats (mean = 0.26, 95% CI = [0.24,
0.28] a.f.u.) (Fig. 4C, D). Similarly, although slightly
delayed, REST expression increased from 6 to
18 months in the CA3 (Fig. 4E, F) and DG (Fig. 4G,
H) regions of wild-type rats. There were no significant
changes in REST expression over time in the hip-
pocampus of TgF344-AD rats. This appeared to be
due to the slightly higher basal levels of nuclear REST
in the hippocampus of 6-month-old TgF344-AD rats
versus 6-month wild-types, coupled with slightly lower
REST expression in 18-month transgenics versus 18-
month wild-types, although these differences were not
statistically significant.
Late synapse loss in hippocampal CA1 region of
18-month TgF344-AD rats
We next investigated if the expression of synapto-
physin, a marker of the presynaptic bouton, changes
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Fig. 1. Amyloid plaque pathology increases with age in the TgF344-AD rat hippocampus. (A) Sagittal section of an 18-month TgF344-AD
(18m TG) rat brain immunofluorescently labelled using (B) the cell nucleus marker DAPI (blue), (C) a conformation-specific Ab1-42 antibody
(green), and (D) the astrocyte marker GFAP (red). Scale bar = 4 mm. Extensive amyloid plaque pathology was observed in the hippocampus
and neocortex and, to a lesser extent, in the thalamus, striatum and cerebellum. Very few amyloid plaques were visualised in the medulla,
pons or ventral midbrain structures, although the inferior colliculus (auditory integration centre) in the dorsal midbrain did show signs of
amyloid plaque pathology. Aged TgF344-AD rats also displayed an increase in astrocyte reactivity. This was particularly evident in the hilus
region of the hippocampal dentate gyrus (white arrowheads), which expressed lower levels of GFAP staining in (E) 6m TG rats, compared
to (F) 12m TG, and (G) 18m TG. Scale bar = 500 µm. Coinciding with this increase in astrocyte reactivity was an enhanced deposition of
Ab1-42 and accumulation of amyloid plaques in all areas of the hippocampus from 6 to 18 months of age. This is clearly seen in
representative images of (H) 6m TG rats, (I) 12m TG and (J) 18m TG. Scale bar = 500 µm. Amyloid plaque pathology was quantified using
the particle analysis tool in ImageJ software. (K) Areas of Ab1-42 staining were thresholded as seen in (L) and the density (M), perimeter (N)
and fluorescence intensity (O) of plaques were quantified in 6-, 12- and 18-month TgF344-AD rats. Data are presented as the mean  95%
confidence intervals and analysed using a one-way ANOVA with Holm-Sidak post hoc test. * represents a p value < 0.05. The number (n) of
rats per group were as follows; 6m TG (n = 7); 12m TG (n = 6); 18m TG (n = 6).
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with age in the CA1, CA3 or dentate gyrus of wild-
type and TgF344-AD rats (Fig. 5A, B). Ageing had a
significant effect on the intensity of synaptophysin
staining in the molecular layer of the dentate gyrus,
which is largely comprised of the dendrites of dentate
granule cells (2-way ANOVA, F2, 30 = 4.37,
P = 0.022). However, there was no effect of genotype
on synaptophysin expression in the dentate gyrus at
any of the ages examined (Fig. 5E). Neither ageing
nor genotype had any effect on synaptophysin expres-
sion in the CA3 region (Fig. 5D). However, both age
(2-way ANOVA, F2, 30 = 6.26, P = 0.005) and geno-
type (2-way ANOVA, F1, 30 = 6.55, P = 0.016) had a
significant effect on synaptophysin levels in the stra-
tum pyramidale and stratum radiatum of the CA1
region (Fig. 5C), which are composed of the cell bod-
ies and axons of CA1 pyramidal neurons, respectively.
Moreover, there was an interaction between age and
genotype in the CA1 region, implying that the effects
of age on synaptophysin levels depend on the genotype
of the rat (2-way ANOVA, F2, 30 = 3.37, P = 0.048).
As such, a decrease in synaptophysin expression was
measured in the CA1 region of 18-month TgF344-AD
rats compared to 18-month wild-types (mean = 0.19,
95% CI = [0.17, 0.21] vs 0.14, 95% CI = [0.13, 0.16]
a.f.u., P = 0.016). Therefore, CA1 pyramidal neurons
of transgenic rats appeared vulnerable to synapse loss
at 18-months of age. However, there were no signifi-
cant differences in synaptophysin expression between
18-month TgF344-AD rats compared to their 12-
month (P = 1.0) and 6-month (P = 0.990) counterparts
and, in all cases, transgenic rats displayed a lower
mean synaptophysin intensity with respect to the 18-
month wild-type rats (18m WT mean = 0.19, 95%
CI = [0.17, 0.21]; 18m TG mean = 0.14, 95%







Fig. 2. REST localises to the nuclear
compartment of cells and is absent from
axons. (A) Representative image of REST
immunofluorescence (white) in the brain
of a 12-month wild-type (12m WT)
Fischer-344 rat. Scale bar = 4 mm. (B–G)
Zoomed-in images from the 12-month WT
rat brain depicted in (A). (B) REST
expression (green) in the anterior olfactory
nucleus. The white arrow points to a
neurofilament-H-labelled axon devoid of
REST staining. Scale bar = 100 µm. (C)
REST expression in the striatum. Scale
bar = 50 µm. (D) REST expression in the
neocortex. Scale bar = 25 µm. REST
predominantly localises to the nuclear
compartment of cells with large nuclei
(yellow arrowhead) and decondensed
chromatin (i.e., faint DAPI staining). These
cells are more likely to be NeuN-positive
neurons than the small nuclei with
condensed chromatin (white arrows), as
described in [63]. (E) REST expression in
the thalamus. Scale bar = 150 µm. (F)
REST expression in the subiculum. Scale
bar = 75 µm. Like most areas in the brain,
REST is localised to larger nuclei with
decondensed chromatin and absent from
neuronal axons. (G) REST expression in
the cerebellar lobule. Scale bar = 150 µm.
There is relatively low expression of REST
in the granule cell layer (green arrowhead)
and the molecular layer (magenta
arrowhead) compared to the Purkinje
neuronal nuclei (white arrowheads). The
Purkinje axons (arbor vitae; yellow
arrowhead) also have low levels of REST.
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Fig. 3. REST increases with age in the subiculum and frontal cortex of wild-type Fischer-344 rats. (A) Sagittal section of an 18-month wild-
type (18m WT) rat brain immunofluorescently-labelled using the cell nucleus marker DAPI (blue), the axonal marker neurofilament-H (red),
and the transcriptional repressor, REST (green). Scale bar = 1 mm. In the more posterior regions of the neocortex, known as the (B)
occipital (OC), (C) parietal (PC), and (D) cingulate cortices (CC), there were no changes in REST expression with age in either WT or TgF344-
AD rats. (E) There were also no changes in REST expression in the thalamus (Thal) in either WT or TgF344-AD rats from 6 to 18 months.
(F) The subiculum (Sub), however, did show elevated REST levels from 6 to 18 months of age, but only in WT rats. (G) Similarly, the frontal
cortex (FC) displayed the largest increases in REST expression from 6 to 18 months, but again only in WT rats. Data are presented as the
mean  95% confidence intervals and analysed using a two-way ANOVA with Holm-Sidak post hoc test. *Represents a P value < 0.05. The
number (n) of rats per group was as follows: 6m WT (n = 5); 12m WT (n = 4); 18m WT (n = 7); 6m TG (n = 8); 12m TG (n = 6); 18m TG
(n = 5).
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Fig. 4. REST increases with age in hippocampal CA1, CA3 and dentate gyrus of wild-type Fischer-344 rats. (A) Sagittal section of the dorsal
hippocampus of an 18-month wild-type (WT) rat and (B) 18-month TgF344-AD (TG) rat immunofluorescently labelled using the cell nucleus
marker DAPI (blue), the axonal marker neurofilament-H (red) and the transcription factor, REST (green). Scale bar = 500 µm. Increased REST
expression was noted in areas corresponding to amyloid plaque deposition (white arrows). (C) Cropped images showing REST expression in
the pyramidal cell layer of the CA1 region in 6-, 12- and 18-month WT and TG rats. Scale bar = 25 µm. (D) REST expression increased in the
CA1 region of WT rats from 6 to 18 months of age, but not in TG rats. (E) Cropped images showing REST expression in the pyramidal cell
layer of the CA3 region in 6-, 12- and 18-month WT and TG rats. Scale bar = 25 µm. (F) REST expression increased in the CA3 region of
WT rats from 6 to 18 months of age, but not in TG rats. (G) Cropped images showing REST expression in the granule cell layer of the
dentate gyrus (DG) in 6, 12 and 18m WT and TG rats. Scale bar = 20 µm. (H) REST expression increased in the DG region of WT rats from
6 to 18 months of age, but not in TG rats. Data are presented as the mean  95% confidence intervals and analysed using a two-way
ANOVA with Holm-Sidak post hoc test. *Represents a P value < 0.05. The number (n) of rats per group were as follows; 6m WT (n = 5);
12m WT (n = 4); 18m WT (n = 7); 6m TG (n = 8); 12m TG (n = 5); 18m TG (n = 5).
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CI = [0.10, 0.18]; 6m TG mean = 0.16, 95%
CI = [0.13, 0.18]).
Hippocampal axonal density decreases with age
in wild-type and TgF344-AD rats
Since 18-month TgF344-AD rats displayed lower
synapse density (measured by synaptophysin staining)
in the CA1 region of the hippocampus, we next mea-
sured expression of the neuronal cytoskeletal interme-
diate filament protein, neurofilament heavy chain
(NFH). When phosphorylated, NFH is involved in the
maintenance of axonal calibre. Hippocampal axonal
density was calculated by counting the number of axon
crossings per unit length in the stratum radiatum of
the CA1, the stratum pyramidale of the CA3 and the
granule cell layer of the dentate gyrus (Fig. 6A, B).
Axonal diameter was also calculated as described in
[27]. Figure 6C–E illustrates a typical neuronal density
trace from the CA1 region of the hippocampus. Inter-
estingly, there were no differences in axonal density at
6, 12 or 18 months between wild-type and TgF344-AD
rats (Fig. 6F–H). Similarly, there were no differences
in axonal diameter between wild-type and TgF344-AD
rats at 6, 12 or 18 months (Fig. 6I–K). However, age-
ing had the largest effect on axonal diameter and den-
sity. In the CA1 region, axonal density decreased from
6 to 18 months in wild-types (mean = 31.47, 95%
CI = [27.47, 35.46] vs 26.35, 95% CI = [23.85, 28.84],
P = 0.016) but not transgenic rats (Fig. 6F). In the
dentate gyrus, axonal density decreased from 6 to
18 months in transgenic rats (mean = 35.44, 95% CI =
[33.17, 37.71] vs 28.75, 95% CI = [27.20, 30.30],
P = 0.007), but not in wild-types (Fig. 6H). This was
accompanied by an age-related increase in axonal
diameter in the DG of TgF344-AD rats (Fig. 6K). The
CA3 region also demonstrated age-associated decreases
in axonal density (Fig. 6G) and increases in axonal
diameter (Fig. 6J) in both wild-type and TgF344-AD
rats.
Ageing and amyloid burden increase reactive
astrogliosis in the hippocampus of wild-type and
TgF344-AD rats
Finally, we measured changes in glial fibrillary acidic
protein (GFAP) expression and astrocyte morphology
in the hippocampus of ageing wild-type and TgF344-
AD rats (Fig. 7A–D). The hippocampus was subdi-
vided into the stratum radiatum of the CA1, the stra-
tum lucidum and pyramidal layer of the CA3, and the
molecular layer of the dentate gyrus. Interestingly, the
average length of astrocyte processes increased from 6
to 12 months in wild-type, but not TgF344-AD rats
(Fig. 7E–G). However, astrocyte branch length then
decreased from 12 to 18 months in wild-type rats
(Fig. 7F, G). In the CA1 region, 18-month TgF344-
AD rats had significantly shorter astrocytic processes
to 18-month wild-types (mean = 17.03 µm, 95% CI =
[16.10, 17.97] vs 19.45 µm, 95% CI = [18.71, 20.18],
P = 0.026) (Fig. 7E). Ageing also impacted the num-
ber of astrocytic processes counted per unit area. Both
wild-type and TgF344-AD rats displayed an increase
in the number of astrocyte processes from 6 to
18 months in all hippocampal areas examined
(Fig. 7H–J). This most likely reflects an increase in the
complexity of individual astrocytes (i.e., a decrease in
branch length and increase in branch number). How-
ever, it may also reflect a concomitant increase in
astrocyte numbers (i.e., astrocyte density). There was a
striking increase in GFAP expression in the hilus
region of the dentate gyrus as well as around amyloid
plaques (Fig. 7B, yellow arrow). As such, there was a
significant increase in astrocyte branch number in the
CA3 region of TgF344-AD rats versus wild-types
(mean = 301.6, 95% CI = [271.7, 331.5] vs 195.1, 95%
CI = [146.7, 243.5], p < 0.0001) (Fig. 7I).
Discussion
The transcription factor, REST, was initially recog-
nised for its important role in neurogenesis [32]. As a
master regulator of neuronal gene expression, it also
plays a key role in shaping the function and plasticity
of mature neurons [33]. Given the wide variety of neu-
ron-specific REST gene targets [34], it has recently
gained recognition as a modulator of neuronal home-
ostasis in both healthy brain ageing and neurodegener-
ative disease contexts [35,36]. However, detailed
mechanistic insight into how REST regulates target
gene expression is still lacking, mainly because of the
large number of candidate genes and the complexity in
deciphering REST’s functional role in their transcrip-
tion or repression [17,37,38]. For example, REST is
known to repress glucocorticoid-mediated induction of
glutamine synthetase (GS) expression in non-neuronal
cells. Conversely, a splice variant of REST (i.e.,
REST4) may enhance GS expression in neurons [39].
Therefore, depending on the context and the gene tar-
get, REST can act as either a repressor or activator of
gene transcription [40]. Moreover, it has been sug-
gested that an increase in REST in cortical neurons
may combat the potentially harmful effects of sus-
tained enhancements in neuronal firing and elevated
glutamatergic synaptic transmission [41,42]. Indeed, an
increase in neuronal activity, as measured by fMRI,
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has been observed in the prefrontal cortex of aged
individuals [43]. However, other studies have shown
that REST activity may be a biomarker of neuronal
senescence [44,45]. Therefore, REST activity may be
enhanced in response to stressful cellular conditions,
but once elevated, REST can exert either protective or
damaging functions, depending on the context [17].
In this study, we show for the first time the spa-
tiotemporal expression profile of nuclear REST
throughout the healthy ageing brain and the brain of
Alzheimer’s disease rats. Here, nuclear REST expres-
sion increases in the frontal cortex from 6 to
18 months, but not in more posterior regions of the
neocortex. Interestingly, we found no significant differ-
ences in the levels of cortical REST between wild-type
and TgF344-AD rats. This is in contrast to the study
by Lu et al. [13] who demonstrated a loss of nuclear
REST in postmortem prefrontal cortex tissue from
human AD patients in comparison with healthy age-
matched controls. However, even though the expected
downregulation of nuclear REST expression did not
occur in the neocortex of TgF344-AD rats, there were
also no significant increases in REST from 6 to
18 months of age. Therefore, if nuclear translocation
of REST is indeed protective in healthy ageing cortical
neurons [36], then failure of neurons to upregulate
nuclear REST in TgF344-AD rats could be equally
detrimental in the context of neurodegenerative dis-
ease. In Alzheimer’s disease, oxidative stress activates
neuronal autophagosomes which can engulf REST
together with other misfolded proteins, such as Ab




Fig. 5. Synaptophysin expression decreases in the hippocampal CA1 region of 18-month TgF344-AD rats. (A) Sagittal section of the dorsal
hippocampus of an 18-month wild-type (WT) rat and (B) 18-month TgF344-AD (TG) rat immunofluorescently labelled using the cell nucleus
marker DAPI (magenta), the amyloid plaque marker Ab1-42 (white), and the presynaptic marker synaptophysin (Syp; green). Scale
bar = 500 µm. (C) There were no significant differences in synaptophysin expression between WT and TG rats at 6 and 12 months of age.
However, 18-month TG rats presented with lower levels of synaptophysin staining at 18-months compared to age-matched WT controls.
Conversely, there were no significant changes in synaptophysin expression with age or amyloid plaque accumulation in the (D) CA3 and (E)
dentate gyrus (DG) regions. Data are presented as the mean  95% confidence intervals and analysed using a two-way ANOVA with Holm-
Sidak post hoc test. * represents a P value < 0.05. The number (n) of rats per group was as follows: 6m WT (n = 4); 12m WT (n = 5); 18m
WT (n = 8); 6m TG (n = 8); 12m TG (n = 6); 18m TG (n = 5).
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Fig. 6. Ageing impacts neuronal density and axonal diameter in the hippocampus of wild-type and TgF344-AD rats. (A) Sagittal section of
the dorsal hippocampus of an 18-month wild-type (WT) rat and (B) 18-month TgF344-AD (TG) rat immunofluorescently-labelled using the
axonal marker neurofilament-H (NFH; white). Scale bar = 500 µm. (C) Cropped image showing the area delineated by the yellow box in (A).
A pseudo-colour palette in (D) highlights the neuronal axons (red) from background NFH staining (teal). Scale bar = 75 µm. The broken
yellow line in (D) corresponds to the broken red line in (E). It transects 23 neuronal axons in the stratum radiatum of the CA1 region of the
hippocampus. Axonal density was measured by calculating the mean number of axons per mm in the CA1, CA3 and dentate gyrus (DG).
The mean axonal diameter was measured by calculating the width at half the height of the peak of NFH fluorescence intensity, as
described in [27]. (F–H) There was a decrease in axonal density in the CA1 and CA3 regions from 6 to 18 months in WT rats. There were
also decreases in axonal density in the CA3 region of TgF344-AD rats from 12 to 18 months, and in the dentate gyrus from 6 to 18 months
of age. (I–K) There were no changes in axonal diameter in the CA1 region of WT or TG rats. However, there were increases in axonal
diameter in the CA3 region from 12 to 18 months of age in both WT and TG rats. Moreover, there was an increase in axonal diameter from
6 to 18 months in the dentate gyrus of TG rats. Data are presented as the mean  95% confidence intervals and analysed using a two-way
ANOVA with Holm-Sidak post hoc test. *Represents a P value < 0.05. The number (n) of rats per group were as follows; 6m WT (n = 5);
12m WT (n = 5); 18m WT (n = 8); 6m TG (n = 8); 12m TG (n = 6); 18m TG (n = 6).
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Fig. 7. Hippocampal astrocyte morphology in wild-type and TgF344-AD rats. (A) Sagittal section of the dorsal hippocampus of an 18-month
wild-type (WT) rat and (B) 18-month TgF344-AD (TG) rat immunofluorescently labelled using the astrocyte marker GFAP (white). Scale
bar = 500 µm. (C–D) Cropped images of the CA1 region of (C) an 18m WT rat and (D) an 18m TG rat, immunofluorescently labelled with
DAPI (blue), Ab1-42 (red) and GFAP (green). Scale bar = 25 µm. Astrocyte morphology was measured by converting the GFAP fluorescence
to a binary image and using the Skeletonize tool in ImageJ software. The average branch length (in µm) and astrocyte density (measured as
number of skeletons per unit area) was calculated in the hippocampal regions depicted in (A). (E–G) There were increases in astrocytic
branch length in all hippocampal regions of WT rats from 6 to 12 months of age. However, astrocyte branch length decreased to 6-month
levels in aged (18-month) WT rats. Astrocyte branch length decreased even further in 18-month TG rats. (H–J) There was an increase in the
mean number of astrocyte (GFAP-positive) branches in both WT and TG rats from 6 to 18 months of age. This could represent either (or
both) an increase in the number of branches per astrocyte or an increase in the total number of astrocytes per unit area. There was a
particularly large increase in astrocyte branch number in the CA3 region of 18m TG rats (i.e., yellow arrow in B). Data are presented as the
mean  95% confidence intervals and analysed using a 2-way ANOVA with Holm-Sidak post hoc test. *Represents a P value < 0.05. The
number (n) of rats per group was as follows: 6m WT (n = 4); 12m WT (n = 5); 18m WT (n = 9); 6m TG (n = 8); 12m TG (n = 6); 18m TG
(n = 6).
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the nucleus may be reduced. In human Parkinson’s
disease brains, REST protein has been found within
cytoplasmic protein aggregates suggesting that protein
inclusions, such as Lewy bodies, can sequester the pro-
tein and prevent nuclear translocation [16]. However,
we did not examine the potential sequestration of
REST protein within the amyloid plaques found in the
TgF344-AD rats.
The hippocampus is particularly vulnerable to dam-
age caused by ischaemic insults, chronic stress, and
neurodegenerative diseases [46,47]. In wild-type ani-
mals, we found that ageing increased nuclear REST
expression in the hippocampus and subiculum, which
is the main output structure of the hippocampus and
receives input from CA1 pyramidal neurons [48]. Inter-
estingly, the subiculum relays inhibitory signals from
the hippocampus to the hypothalamic-pituitary axis
(HPA) to dampen stress responses [49]. Therefore, age-
related nuclear translocation of REST may be more
common in brain regions actively involved in regulat-
ing the response to stress. Again, in our study, REST
nuclear translocation did not occur in the subiculum
or hippocampus (CA1, CA3 and DG) of TgF344-AD
rats with advancing age. In contrast, Lu et al. [13]
reported reduced levels of nuclear REST exclusively in
neurons of the prefrontal cortex and hippocampal neu-
rons (CA1, CA3 and CA4, but not DG) in the human
AD brain. The levels of nuclear REST were not
altered in neurons of the cerebellum, which are less
affected by the classical neuropathological hallmarks
of AD [13,50]. Therefore, the brain regions that dis-
played the most significant increases in nuclear REST
in ageing wild-type rats in the present study, corre-
spond to structures that are strongly impacted by amy-
loid plaque pathology [13]. Thus, if elevations in
nuclear REST are a protective mechanism to defend
neurons against Ab1–42 mediated toxicity, then the
inability of cortical and hippocampal neurons to
increase nuclear REST in the TgF344-AD rat model
likely represents a blunted response to pathological
challenges and could be equally detrimental as a
decrease in REST expression.
Ageing neurons possess larger mitochondria and
undergo structural alterations, including an increase in
axonal diameter [51]. These signs of ageing are often
correlated with increased generation of reactive oxygen
species (ROS) and a disruption to cellular Ca2+ home-
ostasis, which may induce increases in nuclear REST
[51,52]. Here, increases in hippocampal REST expres-
sion in wild-type rats from 6 to 18 months coincided
with a decrease in axonal density in both the CA1 and
CA3 regions, and an increase in axonal diameter,
specifically in the CA3 region. Several studies have
shown that ageing coincides with a decrease in axonal
density in the hippocampus [51,53]. However, the ele-
vated nuclear REST we observed in the CA1 pyrami-
dal cell layer did not protect against axonal loss in the
CA1 stratum radiatum. Nevertheless, augmented levels
of nuclear REST may have helped to protect 18-month
wild-type CA1 neurons from a loss of synapses.
We show here that TgF344-AD rats display a signif-
icant decrease in the presynaptic marker, synapto-
physin (Syp), in CA1 neurons at 18-months of age. At
first, this result appears counterintuitive because the
Syp gene is a target of REST-mediated transcriptional
repression in non-neuronal cells and high levels of
REST activity usually repress the expression of classic
neuronal markers, such as the synaptophysin protein
[54]. However, elevated REST expression in wild-type
CA1 neurons may instead function to silence stress-
and cell death-associated genes, for example members
of the Notch signalling pathway [55,56], and thus
could help to protect wild-type neurons from Ab1–42
mediated loss of synapses indirectly [35]. Indeed,
dynamic and selective regulation of REST target genes
plays an important role in modulating neuronal prop-
erties in both physiological and pathological contexts
[14]. In humans with AD, increased immunoreactivity
for the apoptosis marker FADD has been shown in
cholinergic neurons of the nucleus basalis of Meynert
[57]. Moreover, neuronal progenitor cells derived from
sporadic AD induced pluripotent stem cells (iPSCs)
were shown to have reduced levels of nuclear REST in
comparison to iPSCs derived from normal controls
[58]. This lower expression level of nuclear REST in
sporadic AD iPSCs was linked to decreased binding of
REST to the RE1 motif of target genes, such as
ASCL1, CALB1, DCX, STMN2 and SNAP25, which
led to premature neuronal differentiation, accelerated
synapse formation and increased excitability [58].
Thus, failure to upregulate REST in the TgF344-AD
rat brain may constitute signs of blunted neuroprotec-
tive homeostatic mechanisms and increased vulnerabil-
ity to molecular stressors [13,15,16]. Of note, Meyer
et al. [58] suggested that the magnitude of the reduc-
tion in REST docking to the RE1 binding site within
its target gene chromatin is just as functionally signifi-
cant as the overall reduction in nuclear REST levels.
The increase in hippocampal REST expression in
wild-type rats from 6 to 18 months of age also coin-
cided with an increase in astrogliosis. However, quan-
tification of REST expression was performed in the
pyramidal and granule neuronal cell layers and there-
fore, an increase of nuclear REST predominantly
within neurons would not necessarily prevent glial
reactivity in old age. It has been shown that primary
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cultured astrocytes from astrocyte-specific REST con-
ditional knockout mice display an enhanced inflamma-
tory response to MPP+ (1-methyl-4-phenylpyridinium)
and LPS (lipopolysaccharide) [59]. Moreover, the
inability to recruit REST to the nucleus in response to
the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-te-
trahydropyridine) is also detrimental in neuron-specific
REST conditional knockout mice and results in ele-
vated levels of the pro-inflammatory cytokine, IL-1b,
and increases in GFAP expression in astrocytes [60].
This is interesting because TgF344-AD rats did not
show elevated nuclear REST in response to ageing,
and yet transgenic animals displayed higher levels of
astroglial reactivity and hypertrophy in the hippocam-
pus, particularly in the CA3 and hilar (CA4) regions.
This suggests an interplay between neuron- and glial-
specific REST regulation.
Conclusions
We have shown that nuclear REST increases with
healthy ageing in the frontal cortex, subiculum and
hippocampus of wild-type rats. These brain areas are
important for learning, memory formation, language
and higher cognitive functions and are those most
affected by age-related brain atrophy and neurodegen-
eration [61,62]. REST expression, however, does not
change with age in the TgF344-AD rat model of Alz-
heimer’s disease. There is evidence to suggest that neu-
roinflammation and astrogliosis may be more
pronounced in TgF344-AD rats compared to wild-type
Fischer-344 rats. This dampened REST response in
the TgF344-AD rat brain may be detrimental. More-
over, based on what is currently known about the
functions of REST in various disease contexts, failure
to upregulate nuclear REST activity could prevent key
cellular stress responses from being activated as Ab1–42
plaques gradually accumulate and neurodegenerative
signals increase in the Alzheimer’s disease brain. In
conclusion, our results raise several questions that war-
rant further investigation: (1) Is REST binding affinity
to RE1 binding sites within target gene chromatin
dependent on the brain region analysed or is it possi-
bly age- and/or disease-specific? (2) How are neigh-
bouring glial cells affected by the failure of neurons to
upregulate REST in the context of Alzheimer’s disease
pathogenesis?
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